M

MeiraGTx Holdings plc

MGTX

4.86000
USD
-0.37
(-7.07%)
مغلق
حجم التداول
3,224
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
462,333,280
أصول ذات صلة
A
AGIO
-1.950
(-4.20%)
44.520 USD
B
BPMC
-8.610
(-7.94%)
99.770 USD
F
FOLD
-0.140
(-1.36%)
10.180 USD
G
GLYC
-0.00060
(-0.28%)
0.21540 USD
M
MRSN
-0.20500
(-10.22%)
1.80000 USD
M
MRTX
0
(0%)
0.000000 USD
P
PIRS
0.480
(2.91%)
16.990 USD
P
PRVB
-0.075
(-0.31%)
23.870 USD
R
RGNX
-0.920
(-6.44%)
13.370 USD
الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.